Clinical trials
Glioma trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 7 |
| Not yet recruiting | 4 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut du Cancer de Montpellier - Val d'Aurelle | 5 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Boston Scientific Corporation | 1 |
| Center Eugene Marquis | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Antoine Lacassagne | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Jean Perrin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 28 |
| Brain Neoplasms | 6 |
| Breast Neoplasms | 3 |
| Glioblastoma | 3 |
| Neoplasms | 3 |
| Colonic Neoplasms | 1 |
| Communication Disorders | 1 |
| Disease | 1 |
| Epilepsy | 1 |
| Hypoxia | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.